Description

Solifenacin Succinate Tablets IP 5 Mg – SOLSENCE 5 Tablets

Description
SOLSENCE 5 contains Solifenacin Succinate Tablets IP 5 mg, a selective muscarinic receptor antagonist (anticholinergic) indicated for the treatment of overactive bladder (OAB) syndrome. It works by blocking M3 muscarinic receptors in the detrusor muscle of the bladder, reducing involuntary bladder contractions and resulting in relieving symptoms of urgency, urge incontinence, and urinary frequency. The 5 mg strength is typically prescribed as the initial dose for patients to achieve effective symptom control with good tolerability.

Key Points
Selective M3 Muscarinic Antagonist — Targets bladder smooth muscle specifically for effective OAB control

Starting Dose Option — 5 mg dose for initiating therapy with good tolerability

Reduces Urgency & Frequency — Significantly decreases episodes of urge urinary incontinence and frequent urination

Once Daily Dosing — Improves patient adherence with a simple, convenient regimen

Sustained 24-Hour Bladder Control — Long-acting formulation for round-the-clock symptom relief

Targeted Specialties
Urology
Gynaecology & Urogynaecology
General Physician & Internal Medicine
Geriatrics
Nephrology

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.